| Autor: |
Chakrabarti, Katherine, Swartz, Leigh K, Gill, Anoop, Fang, Fang, Kidwell, Kelley M, Morikawa, Aki |
| Zdroj: |
CNS Oncology; September 2020, Vol. 9 Issue: 3 |
| Abstrakt: |
Background:The aim of this study was to identify risk factors that may predispose breast cancer patients to the development of CNS metastases. Materials & methods:We conducted a matched case–control study of breast cancer patients treated with surgery with curative intent. A total of 71 cases and 71 controls were analyzed, matched by year of surgery. Results:In our multivariable model, positive lymph node status (odds ratio [OR]: 5.08; CI: 2.04–12.65), the use of neoadjuvant chemotherapy (OR: 6.02; CI: 2.06–17.57) and triple-negative breast cancer (OR: 5.44; CI: 1.99–14.90) were statistically significant predictors of the development of CNS metastases. Conclusion:Women with certain risk factors have an increased odds of developing CNS metastases and evaluation of utility in brain metastases screening should be considered. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
